Start Date
September 30, 2019
Primary Completion Date
November 30, 2021
Study Completion Date
April 30, 2022
Botulinum Toxin Type A 100U
one intra-articular injection of 100 U of botulinum toxin type A, diluted in 2 ml of 0.9% SSI
Botulinum Toxin Type A 200U
one intra-articular injection of 200 U of botulinum toxin type A, diluted in 4 ml of 0.9% SSI
Triamcinolone Hexacetonide Inj Susp 20 MG/ML
one intra-articular injection of 2 ml Triamcinolone Hexacetonide
Lille Catholic University, Lille
Collaborators (1)
Allergan
INDUSTRY
Lille Catholic University
OTHER